These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 3304356)
1. Analysis of human serum antibodies to human immunodeficiency virus (HIV) using recombinant ENV and GAG antigens. Kenealy W; Reed D; Cybulski R; Tribe D; Taylor P; Stevens C; Matthews T; Petteway S AIDS Res Hum Retroviruses; 1987; 3(1):95-105. PubMed ID: 3304356 [TBL] [Abstract][Full Text] [Related]
2. Comparison of recombinant human immunodeficiency virus gag precursor and gag/env fusion proteins and a synthetic env peptide as diagnostic reagents. Shoeman RL; Young D; Pottathil R; Victor J; Conroy RR; Crowl RM; Coleman T; Heimer E; Lai CY; Ganguly K Anal Biochem; 1987 Mar; 161(2):370-9. PubMed ID: 3495201 [TBL] [Abstract][Full Text] [Related]
3. Antibodies reactive with human immunodeficiency virus gag-coded antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a blood donor population. Tribe DE; Reed DL; Lindell P; Kenealy WR; Ferguson BQ; Cybulski R; Winslow D; Waselefsky DM; Petteway SR J Clin Microbiol; 1988 Apr; 26(4):641-7. PubMed ID: 3259246 [TBL] [Abstract][Full Text] [Related]
4. Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes. Ng VL; Chiang CS; Debouck C; McGrath MS; Grove TH; Mills J J Clin Microbiol; 1989 May; 27(5):977-82. PubMed ID: 2787334 [TBL] [Abstract][Full Text] [Related]
5. Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects. Manca N; di Marzo Veronese F; Ho DD; Gallo RC; Sarngadharan MG Eur J Epidemiol; 1987 Jun; 3(2):96-102. PubMed ID: 3497054 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens. Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590 [TBL] [Abstract][Full Text] [Related]
7. A new ELISA test for HIV antibodies using a bacterially produced viral env gene product. Schneider J; Wendler I; Guillot F; Hunsmann G; Gallati H; Schoenfeld HJ; Stüber D; Mous J Med Microbiol Immunol; 1987; 176(1):47-51. PubMed ID: 3547057 [TBL] [Abstract][Full Text] [Related]
8. Reactivity of an HIV gag gene polypeptide expressed in E. coli with sera from AIDS patients and monoclonal antibodies to gag. Marcus-Sekura CJ; Woerner AM; Klutch M; Quinnan GV Biochim Biophys Acta; 1988 Feb; 949(2):213-23. PubMed ID: 2449245 [TBL] [Abstract][Full Text] [Related]
10. [Serologic AIDS diagnosis with polypeptides obtained by genetic technics of the human immunodeficiency virus (HIV-1)]. Lenz A; von Hintzenstern J; Erlwein O; Ellinger S; Bröker M; Fleckenstein B; Jahn G Klin Wochenschr; 1987 Nov; 65(21):1042-7. PubMed ID: 3323645 [TBL] [Abstract][Full Text] [Related]
11. Use of the recombinant chimera proteins, LacZ-Env and Gag-Env, for immunological studies on HIV-1 infection. Morimoto M; Saitoh A; Ueba N; Nakata A; Shinagawa H AIDS Res Hum Retroviruses; 1993 Oct; 9(10):971-8. PubMed ID: 7506555 [TBL] [Abstract][Full Text] [Related]
12. Prognostic importance of antibodies to human immunodeficiency virus by recombinant immunoassay and Western blot techniques in HIV antibody-positive hemophiliacs. Ragni MV; O'Brien TA; Reed D; Spero JA; Lewis JH AIDS Res Hum Retroviruses; 1988 Jun; 4(3):223-31. PubMed ID: 3165003 [TBL] [Abstract][Full Text] [Related]
13. Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody. Thorn RM; Beltz GA; Hung CH; Fallis BF; Winkle S; Cheng KL; Marciani DJ J Clin Microbiol; 1987 Jul; 25(7):1207-12. PubMed ID: 3475281 [TBL] [Abstract][Full Text] [Related]
14. Reliable detection of individuals seropositive for the human immunodeficiency virus (HIV) by competitive immunoassays using Escherichia coli-expressed HIV structural proteins. Dawson GJ; Heller JS; Wood CA; Gutierrez RA; Webber JS; Hunt JC; Hojvat SA; Senn D; Devare SG; Decker RH J Infect Dis; 1988 Jan; 157(1):149-55. PubMed ID: 3275722 [TBL] [Abstract][Full Text] [Related]
15. Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41). Filice G; Soldini L; Orsolini P; Razzini E; Chiapparoli L; Gulminetti R; Cattaneo E; Achilli G Microbiologica; 1991 Jan; 14(1):1-7. PubMed ID: 1906127 [TBL] [Abstract][Full Text] [Related]
16. Human T-cell lymphotropic virus type III (HTLV-III) core antigens: synthesis in Escherichia coli and immunoreactivity with human sera. Ghrayeb J; Kato I; McKinney S; Huang JJ; Chanda PK; Ho DD; Sarangadharan MG; Chang TW; Chang NT DNA; 1986 Apr; 5(2):93-9. PubMed ID: 3011373 [TBL] [Abstract][Full Text] [Related]
17. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome]. Schulte C; Meurer M; Fröschl M Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727 [TBL] [Abstract][Full Text] [Related]
18. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects. Klasse PJ; Pipkorn R; Blomberg J Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. Gnann JW; Schwimmbeck PL; Nelson JA; Truax AB; Oldstone MB J Infect Dis; 1987 Aug; 156(2):261-7. PubMed ID: 2439614 [TBL] [Abstract][Full Text] [Related]
20. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles. Kang CY; Luo L; Wainberg MA; Li Y Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]